Peer-reviewed veterinary case report
How common are hormone problems in diabetic cats in Buenos Aires
By D. Miceli et al.·Published in Journal of feline medicine and surgery·2023·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Prevalence of hypersomatotropism and hyperthyroidism in cats with diabetes mellitus from referral centers in Buenos Aires (2020–2022)
- Species:
- cat
Plain-English summary
A study found that among 154 diabetic cats in Buenos Aires, 20 cats (about 13%) had a condition called hypersomatotropism (HST), which is linked to high levels of a growth hormone. This condition can cause symptoms like increased appetite and abnormal growth. Additionally, only 4 cats (around 2.5%) had hyperthyroidism, which is less common in diabetic cats. The researchers used imaging to check for changes in the pituitary gland, and many cats showed signs of acromegaly, a condition associated with HST. Understanding these conditions can help veterinarians provide better care for diabetic cats.
People also search for: cat diabetes symptoms · hypersomatotropism in cats · hyperthyroidism in diabetic cats · acromegaly in cats · cat diabetes treatment options
Abstract
Objectives The aim of this study was to estimate the prevalence of hypersomatotropism (HST) and hyperthyroidism in cats with diabetes mellitus (DM) from referral centers in Buenos Aires, Argentina. Methods This was a prospective study. Systematic screening of serum insulin-like growth factor 1 (IGF-1) and total thyroxine was performed in all cats diagnosed with DM at referral centers in Buenos Aires between February 2020 and February 2022. Results In total, 154 diabetic cats were evaluated (99 males and 55 females; median age 12 years [range 3–21]; mean body weight 5 kg [range 2–12]). Altogether, there were 115 (75%) domestic shorthairs and one domestic longhair; the remaining 38 cats were purebred (mainly Siamese, n = 25 [16%]). Twenty (12.9%) cats had IGF-1 concentrations >1000 ng/ml, and three (1.9%) had IGF-1 concentrations between 800 and 1000 ng/ml along with pituitary enlargement on CT, resulting in a 14.9% HST prevalence rate in diabetic cats. Intracranial imaging was performed in all cats with HST; median pituitary dorsoventral height was 5.8 mm (range 3.1–9.5). Fourteen of 23 (61%) cats had phenotypic changes consistent with acromegaly at the time of diagnosis of HST. Four of 154 (2.5%) cats had concurrent hyperthyroidism. Conclusions and relevance To date, this is the first study outside of Europe to have evaluated the prevalence of HST and hyperthyroidism in cats with DM. In Buenos Aires referral centers, feline HST is the most common concurrent endocrinopathy in cats with DM but with a lower prevalence than has previously been reported. Hyperthyroidism is a rare concurrent endocrinopathy in diabetic cats from referral centers in Buenos Aires.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/36779783